just look up relenza on google news,there s a good write up from usa today,were gsk say they can produce max 500 000 relenza,at us $50 a pop!theres plenty of flu news,such as it could cost $200 mill in lost productivity,sure hope someone gets flunet into trials , if it works like biota says,it would dominate the flu treatment market
